Back to Stakeholders

Ketamine therapy platform combining telehealth, digital treatment flow, and app-guided support for depression and related mental health conditions.

Technology, Data, & Software Snapshot

Digital Therapeutics

Platform Model

Digital Therapeutics Product

Deployment

SaaS Application

Geography

National

Coverage

1 country

Customer Types

Patient / Consumer PopulationsClinical Providers / Networks

Capability Focus Areas

Digital Care Pathways

Data Modalities

Patient-Reported OutcomesBehavioral / Survey Data

Technology Notes

Mindbloom operates a software-enabled ketamine care pathway with psychedelic-adjacent digital therapeutic support.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Last Verified

Apr 9, 2026

Primary Platform Link

Quick Facts

HQ
New York, United States
Website
Visit